miR 31-3p Has the Highest Expression in Cesarean Scar Endometriosis
article
OA: gold
CC0
⤵ 2 in-corpus citations
Abstract
Micro-RNAs expression can vary between different forms of endometriosis, but data on miRNA expression in cesarean scar endometriosis is lacking. The present study is comprised of 30 patients with endometriosis in the cesarean scar (scar endometriosis, SE), 14 patients with deep infiltrating endometriosis (DIE), 47 patients with endometrioma (ovarian endometrial cyst, OE), and 33 patients with healthy ovarian tissue as the control group (CG). In the initial experiment to identify possible dysregulated miRNAs, the levels of 754 miRNAs in formalin-fixed paraffin-embedded tissue (FFPE) samples from OE, high-grade ovarian cancer, endometrioid ovarian cancer, and CG were measured. We identified seven potentially dysregulated miRNAs: miR-1-3p, miR-31-3p, miR-125b-1-3p, miR-200b-3p, miR-548d, miR-502, and miR-503. We then examined the expression profiles of each of these miRNAs individually in the SE, DIE, OE, and CG FFPE samples using RT-qPCR. miR-31-3p had significantly higher levels of expression and miR-125b-1-3p had significantly lower levels of expression in SE compared to the controls. Overall, the higher expression levels of miR-31-3p and the lower expression levels of miR-125b-1-3p are consistent with the benign nature of SE. Importantly, the results of the present study demonstrate the possibility of using miRNA to monitor the risk of malignant transformation of endometriosis tissue.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (46)
- Circulating serum miR-200c and miR-34a-5p as diagnostic biomarkers for endometriosis via openalex
- Comparative Analysis of Differentially Expressed miRNAs and their Downstream mRNAs in Ovarian Cancer and its Associated Endometriosis via openalex
- Eutopic Endometrium in Women with Endometriosis: Ground Zero for the Study of Implantation Defects via openalex
- Ovarian endometriosis, a precursor of ovarian cancer: Histological aspects, gene expression and microRNA alterations (Review) via openalex
- Overexpression of miR-200b-3p in Menstrual Blood-Derived Mesenchymal Stem Cells from Endometriosis Women via openalex
- Profiling of Selected MicroRNAs in Proliferative Eutopic Endometrium of Women with Ovarian Endometriosis via openalex
- Recognizing and treating endometriosis via openalex
- Rectovaginal endometriosis – a frequently missed diagnosis via openalex
- Role of miRNAs in Normal Endometrium and in Endometrial Disorders: Comprehensive Review via openalex
- W2105316240 via openalex
- W2117692326 via openalex
- W2141948830 via openalex
- W2151922790 via openalex
- W2162289930 via openalex
- W2165034468 via openalex
- W2168859271 via openalex
- W2189097051 via openalex
- W2235560983 via openalex
- W2288482887 via openalex
- W2396315569 via openalex
- W2414799984 via openalex
- W2568075826 via openalex
- W2616020723 via openalex
- W2621106537 via openalex
- W2624026115 via openalex
- W2734474023 via openalex
- W2794241440 via openalex
- W2811212358 via openalex
- W2895011886 via openalex
- W2944903972 via openalex
- W2946714259 via openalex
- W3094548038 via openalex
- W3162869038 via openalex
- W3199530227 via openalex
- W3202531905 via openalex
- W4221121650 via openalex
- W6712480487 via openalex
- W6717938025 via openalex
- W1781739971 via openalex
- W1976324983 via openalex
- W2004462371 via openalex
- W2025021247 via openalex
- W2060074160 via openalex
- W2066081464 via openalex
- W2078564924 via openalex
- W2099163426 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-29T00:34:44.584713+00:00
License: CC0
· commercial use OK